Skip to main content
رجوع
SRRK logo

Scholar Rock Holding Corporation

جودة البيانات: 100%
SRRK
NASDAQ Healthcare Biotechnology
KWD 43.66
▼ KWD 0.98 (-2.20%)
القيمة السوقية: 5.02B
نطاق اليوم
KWD 43.46 KWD 45.92
نطاق 52 أسبوعًا
KWD 22.71 KWD 49.82
حجم التداول
1,267,776
متوسط 50 يوم / 200 يوم
KWD 45.04 / KWD 38.36
الإغلاق السابق
KWD 44.64

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (626 نظير)

المقياس السهم وسيط القطاع
P/E -13.3 0.4
P/B 20.4 2.9
ROE % -123.1 3.7
Net Margin % 3.8
Rev Growth 5Y % 10.0
D/E 0.4 0.2

النقاط الرئيسية

Debt/Equity of 0.44 — conservative balance sheet
Negative free cash flow of -300.64M

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
-123.08%
ROIC-81.40%
Net MarginN/A
Op. MarginN/A

الأمان

Debt / Equity
0.44
Current Ratio6.95
Interest Coverage-55.80

التقييم

P/E Ratio
-13.27
P/B Ratio20.43
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 0.0 Net Income (TTM) -377.94M
ROE -123.08% ROA -93.49%
Gross Margin N/A Operating Margin N/A
Net Margin N/A Free Cash Flow (TTM) -300.64M
ROIC -81.40% FCF Growth (3Y) N/A
Safety
Debt / Equity 0.44 Current Ratio 6.95
Interest Coverage -55.80 Dividend Yield 0.00%
Valuation
P/E Ratio -13.27 P/B Ratio 20.43
P/S Ratio N/A PEG Ratio -0.40
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 5.02B Enterprise Value 4.80B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 0.0 0.0 0.0 33.19M 18.82M
Net Income -377.94M -246.29M -165.79M -134.50M -131.80M
EPS (Diluted) -3.29 -2.47 -1.99 -2.21 -3.59
Gross Profit -1.66M -1.94M -2.84M -89.85M -89.65M
Operating Income -384.65M -252.05M -171.30M -134.37M -129.92M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 404.27M 474.92M 311.04M 358.17M 304.45M
Total Liabilities 158.78M 106.29M 85.82M 97.93M 132.37M
Shareholders' Equity 245.49M 368.63M 225.22M 260.24M 172.07M
Total Debt 108.92M 65.13M 61.82M 69.40M 84.47M
Cash & Equivalents 323.53M 177.88M 101.86M 103.28M 212.84M
Current Assets 385.15M 451.17M 288.19M 328.02M 265.32M
Current Liabilities 55.42M 46.94M 32.74M 36.39M 64.30M